Skip to main content
. 2019 Jan 17;14(1):e0210476. doi: 10.1371/journal.pone.0210476

Table 2. ARV regimens directly before the switch to DLT/DRV/r.

Type of therapy N (%)
Standard three-drug combination with two NRTIs and one boosted PI 39
Standard three-drug combination with two NRTIs and one NNRTI 4
Standard three-drug combination with two NRTIs and one InI 4
Two- drug combination 19
Non-standard three-drug combination 6
Four-drug combination 4

NRTI—nucleoside/nucleotide reverse transcriptase inhibitors

NNRTI-non-nucleoside reverse transcriptase inhibitorsPI- protease inhibitors

InI- integrase inhibitors